OpenVSafe by OpenVAERS
Search V-safe

ZXW-30931-71303

2 vaccinations 6 coded responses 7 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
141 / NY
Registered
2021-04-30
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-04-02
    Dose 1 — Moderna
  2. 2021-04-30
    Registered in v-safe
  3. 2021-04-30
    Dose 2 — Moderna
  4. 2021-04-30
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Swelling · Muscle or body aches · Be unable to work
    Adult check-in
  5. 2021-05-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Flat affect — Feeling: Good · Muscle or body aches · Be unable to work, Be unable to do your normal daily activities
    Free text: Early bedtime. Somewhat flat affect.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Affect lability, Feeling abnormal — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Mental fog, emotionally labile
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-14
    Survey response — day 14, dose 2
    MedDRA: Ageusia, Anosmia, Fatigue, Feeling of body temperature change — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: At 2 weeks post-2nd Moderna shot: Fatigue Feeling hot & chilly at the same time. Intermittent but complete loss of smell & taste.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-21
    Survey response — day 21, dose 2
    MedDRA: Ageusia, Anosmia, Asthenia, Brain fog, Chills, Feeding disorder, Hyperhidrosis, Insomnia, Medical counselling — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Ongoing, severe loss or distorted loss of smell/ taste, usually debilitating & causing inability to eat, weakness, & inability to function normally. Ongoing periods of chills/sweats/ shivering. Brain fog. Insomnia. · Healthcare visit (other): Primary care Physcn; longtime local pharmacist.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-21
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-05-28
    Survey response — day 28, dose 2
    MedDRA: Ageusia, Anosmia, Chills, Hyperhidrosis, Nausea, Pyrexia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: No sense of taste; all smells either non-existent, or so foul as to cause debilitating nausea. Chills/sweats/intermittent fever.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-06-06
    Survey response — day 35, dose 2
    MedDRA: Brain fog, Chills, Fatigue, Hyperhidrosis — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Persistent fatigue; insomnia; chills/sweats at same time; periodic unsteady gait; unreliable memory re: date, time, previous conversations.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2022-05-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-02Moderna
22021-04-30Moderna

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-05

Systemic reaction (other): Early bedtime. Somewhat flat affect.

2021-05-06

Systemic reaction (other): Mental fog, emotionally labile

Release 8 — day 14, dose 2

2021-05-14

Symptoms: At 2 weeks post-2nd Moderna shot: Fatigue Feeling hot & chilly at the same time. Intermittent but complete loss of smell & taste.

Release 8 — day 21, dose 2

2021-05-21

Symptoms: Ongoing, severe loss or distorted loss of smell/ taste, usually debilitating & causing inability to eat, weakness, & inability to function normally. Ongoing periods of chills/sweats/ shivering. Brain fog. Insomnia.
Healthcare visit (other): Primary care Physcn; longtime local pharmacist.

Release 8 — day 28, dose 2

2021-05-28

Symptoms: No sense of taste; all smells either non-existent, or so foul as to cause debilitating nausea. Chills/sweats/intermittent fever.

Release 8 — day 35, dose 2

2021-06-06

Symptoms: Persistent fatigue; insomnia; chills/sweats at same time; periodic unsteady gait; unreliable memory re: date, time, previous conversations.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SDAgeusia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDBrain fog ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFeeding disorder ✓ ✓ ✓
SDFeeling of body temperature change ✓ ✓ ✓
SDHyperhidrosis ✓ ✓ ✓
SDInsomnia ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SROAffect lability ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROFlat affect ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…